Serina Therapeutics (SER) Notes Payables (2017 - 2022)

Serina Therapeutics has disclosed Notes Payables across 6 years of filings, most recently posting $141000.0 for Q4 2022.

• In Q4 2022, Notes Payables rose 101.43% year-over-year to $141000.0; the TTM figure through Dec 2022 stood at $141000.0 (up 101.43% YoY), while the FY2022 annual figure was $141000.0, up 101.43% from the prior year.
• Notes Payables came in at $141000.0 for Q4 2022 at Serina Therapeutics, up from $59000.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $7.0 million in Q2 2022 to a low of $59000.0 in Q3 2022.
• Average Notes Payables over 5 years is $2.1 million, with a median of $1.8 million recorded in 2020.
• Year-over-year, Notes Payables jumped 2962.5% in 2020 and tumbled 98.95% in 2022.
• Over 5 years, Notes Payables stood at $132000.0 in 2018, then sank by 51.52% to $64000.0 in 2019, then jumped by 2962.5% to $2.0 million in 2020, then plunged by 96.43% to $70000.0 in 2021, then jumped by 101.43% to $141000.0 in 2022.
• Per Business Quant data, the three most recent Notes Payables figures were $141000.0 in Q4 2022, $59000.0 in Q3 2022, and $7.0 million in Q2 2022.